Masimo Revenue 2010-2025 | MASI

Masimo annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Masimo revenue for the quarter ending March 31, 2025 was $372M, a 9.54% increase year-over-year.
  • Masimo revenue for the twelve months ending March 31, 2025 was $2.127B, a 16.68% increase year-over-year.
  • Masimo annual revenue for 2024 was $2.094B, a 2.26% increase from 2023.
  • Masimo annual revenue for 2023 was $2.048B, a 0.6% increase from 2022.
  • Masimo annual revenue for 2022 was $2.036B, a 64.28% increase from 2021.
Masimo Annual Revenue
(Millions of US $)
2024 $2,094
2023 $2,048
2022 $2,036
2021 $1,239
2020 $1,144
2019 $938
2018 $858
2017 $790
2016 $713
2015 $630
2014 $587
2013 $547
2012 $493
2011 $439
2010 $405
2009 $349
Masimo Quarterly Revenue
(Millions of US $)
2025-03-31 $372
2024-12-31 $754
2024-09-30 $505
2024-06-30 $496
2024-03-31 $340
2023-12-31 $549
2023-09-30 $479
2023-06-30 $455
2023-03-31 $565
2022-12-31 $617
2022-09-30 $549
2022-06-30 $565
2022-03-31 $304
2021-12-31 $328
2021-09-30 $307
2021-06-30 $305
2021-03-31 $299
2020-12-31 $295
2020-09-30 $278
2020-06-30 $301
2020-03-31 $270
2019-12-31 $248
2019-09-30 $229
2019-06-30 $230
2019-03-31 $232
2018-12-31 $223
2018-09-30 $211
2018-06-30 $212
2018-03-31 $213
2017-12-31 $208
2017-09-30 $193
2017-06-30 $192
2017-03-31 $197
2016-12-31 $201
2016-09-30 $168
2016-06-30 $173
2016-03-31 $171
2015-12-31 $167
2015-09-30 $153
2015-06-30 $156
2015-03-31 $155
2014-12-31 $162
2014-09-30 $144
2014-06-30 $141
2014-03-31 $140
2013-12-31 $142
2013-09-30 $131
2013-06-30 $137
2013-03-31 $136
2012-12-31 $132
2012-09-30 $119
2012-06-30 $123
2012-03-31 $119
2011-12-31 $112
2011-09-30 $104
2011-06-30 $110
2011-03-31 $113
2010-12-31 $106
2010-09-30 $101
2010-06-30 $100
2010-03-31 $99
2009-12-31 $93
2009-09-30 $87
2009-06-30 $84
2009-03-31 $85
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.086B $2.094B
Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $195.148B 85.47
Thermo Fisher Scientific (TMO) United States $162.069B 19.60
Edwards Lifesciences (EW) United States $45.045B 29.53
IDEXX Laboratories (IDXX) United States $43.992B 50.56
Alcon (ALC) Switzerland $43.297B 29.26
DexCom (DXCM) United States $32.517B 50.26
IQVIA Holdings (IQV) United States $28.414B 15.91
Mettler-Toledo (MTD) United States $25.128B 29.88
STERIS (STE) Ireland $23.368B 25.74
Waters (WAT) United States $20.841B 29.41
SONOVA HOLDING (SONVY) Switzerland $17.678B 0.00
Hologic (HOLX) United States $14.436B 15.69
Sysmex ADR (SSMXY) Japan $10.859B 30.80
Penumbra (PEN) United States $9.723B 76.31
Globus Medical (GMED) United States $8.010B 19.09
Glaukos (GKOS) United States $5.914B 0.00
Teleflex (TFX) United States $5.298B 8.75
TransMedics (TMDX) United States $4.370B 94.99
Integer Holdings (ITGR) United States $4.222B 22.12
PROCEPT BioRobotics (PRCT) United States $3.205B 0.00
LivaNova (LIVN) United Kingdom $2.515B 14.98
Nihon Kohden (NHNKY) Japan $2.346B 26.90
Veracyte (VCYT) United States $2.154B 30.23
Elekta AB (EKTAY) Sweden $1.991B 17.90
Alphatec Holdings (ATEC) United States $1.606B 0.00
Artivion (AORT) United States $1.312B 122.88
Tandem Diabetes Care (TNDM) United States $1.118B 0.00
OPKO Health (OPK) United States $1.079B 0.00
Integra LifeSciences Holdings (IART) United States $1.048B 5.57
Pulse Biosciences (PLSE) United States $1.029B 0.00
SiBone (SIBN) United States $0.787B 0.00
IRadimed (IRMD) United States $0.786B 39.87
Beta Bionics (BBNX) United States $0.586B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.571B 8.88
Mesa Laboratories (MLAB) United States $0.564B 13.22
OrthoPediatrics (KIDS) United States $0.546B 0.00
RxSight (RXST) United States $0.530B 0.00
AxoGen (AXGN) United States $0.498B 0.00
Pacific Biosciences Of California (PACB) United States $0.480B 0.00
Semler Scientific (SMLR) United States $0.451B 12.00
Delcath Systems (DCTH) United States $0.442B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.436B 0.00
AngioDynamics (ANGO) United States $0.389B 0.00
Treace Medical Concepts (TMCI) United States $0.389B 0.00
NeuroPace (NPCE) United States $0.341B 0.00
ClearPoint Neuro (CLPT) United States $0.327B 0.00
Biosig Technologies (BSGM) United States $0.284B 0.00
Alpha Tau Medical (DRTS) Israel $0.269B 0.00
908 Devices (MASS) United States $0.238B 0.00
Tactile Systems Technology (TCMD) United States $0.236B 14.27
Neuronetics (STIM) United States $0.224B 0.00
Sight Sciences (SGHT) United States $0.218B 0.00
Inogen (INGN) United States $0.201B 0.00
CVRx (CVRX) United States $0.172B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
Rapid Micro Biosystems (RPID) United States $0.159B 0.00
LENSAR (LNSR) United States $0.155B 0.00
Accuray (ARAY) United States $0.146B 0.00
Anteris Technologies Global (AVR) Australia $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.111B 0.00
Atossa Genetics (ATOS) United States $0.110B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.077B 46.60
EnVVeno Medical (NVNO) United States $0.070B 0.00
InspireMD (NSPR) United States $0.069B 0.00
Spectral AI (MDAI) United States $0.068B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
EDAP TMS S.A (EDAP) France $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.052B 21.11
Vicarious Surgical (RBOT) United States $0.045B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Envoy Medical (COCH) United States $0.033B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.026B 0.00
Adagio Medical Holdings (ADGM) United States $0.024B 0.00
NexGel (NXGL) United States $0.020B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
WORK Medical Technology Group (WOK) China $0.010B 0.00
PAVmed (PAVM) United States $0.010B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Ekso Bionics Holdings (EKSO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.07
Longview Acquisition II (LGV) United States $0.000B 0.00